3. Norman FF, Rojas-Marcos J, Hermida-Donate JM, Monge-Maillo B, Perez-Molina JA, López-Vélez R. 2014; Splenic infarction and malaria. Trans R Soc Trop Med Hyg. 108:455–460. DOI:
10.1093/trstmh/tru095. PMID:
24942899.
Article
4. Linthicum KJ, Anyamba A, Killenbeck B, Lee WJ, Lee HC, Klein TA, et al. 2014; Association of temperature and historical dynamics of malaria in the Republic of Korea, including reemergence in 1993. Mil Med. 179:806–814. DOI:
10.7205/MILMED-D-13-00545. PMID:
25003869.
Article
5. World Health Organization. 1981; Synopsis of the world malaria situation, 1979. Wkly Epidemiol Rec. 56:145–149.
6. Chang KS, Yoo DH, Ju YR, Lee WG, Roh JY, Kim HC, et al. 2016; Distribution of malaria vectors and incidence of vivax malaria at Korean army installations near the demilitarized zone, Republic of Korea. Malar J. 15:259. DOI:
10.1186/s12936-016-1301-y. PMID:
27150110. PMCID:
PMC4858856.
Article
7. Yeom JS, Ryu SH, Oh S, Choi DH, Song KJ, Oh YH, et al. 2005; Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army. J Korean Med Sci. 20:707–712. DOI:
10.3346/jkms.2005.20.5.707. PMID:
16224140. PMCID:
PMC2779263.
Article
8. Park SY, Park YS, Park Y, Kwak YG, Song JE, Lee KS, et al. 2019; Severe vivax malaria in the Republic of Korea during the period 2000 to 2016. Travel Med Infect Dis. 30:108–113. DOI:
10.1016/j.tmaid.2019.04.013. PMID:
31054320.
Article
9. Lim HS, Im JS, Cho JY, Bae KS, Klein TA, Yeom JS, et al. 2009; Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax. Antimicrob Agents Chemother. 53:1468–1475. DOI:
10.1128/AAC.00339-08. PMID:
19188392. PMCID:
PMC2663072.
Article
10. Imbert P, Rapp C, Buffet PA. 2009; Pathological rupture of the spleen in malaria: analysis of 55 cases (1958-2008). Travel Med Infect Dis. 7:147–159. DOI:
10.1016/j.tmaid.2009.01.002. PMID:
19411041.
Article